America’s Blood Centers (ABC) is providing feedback to the Solicitation for Public Comments on Section 209 of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act. ABC thanks HHS for soliciting public comments on this important report and for providing the additional time needed to assemble invaluable lessons learned during the beginning of this current…
Read MoreThe following statement has been issued by AABB, America’s Blood Centers and the American Red Cross regarding the status of the nation’s blood supply: Since the beginning of the COVID-19 pandemic, AABB, America’s Blood Centers, the American Red Cross, and others in the blood community have been working together to monitor the nation’s blood supply…
Read MoreAABB, America’s Blood Centers and the American Red Cross – which collectively represent the nation’s blood collection establishments, transfusion services, and transfusion medicine professionals – appreciate the Department of Health and Human Services’ ongoing support for the blood community and commend the Centers for Medicare and Medicaid Services (CMS) for developing recommendations for health care…
Read MoreAABB, America’s Blood Centers and the American Red Cross are requesting funding to pay for COVID-19 convalescent plasma (CCP) that is not otherwise reimbursed. Our organizations – which collectively represent the nation’s blood collection establishments, transfusion services, and transfusion medicine professionals – are working hard to collect and deliver CCP to patients recovering from COVID-19…
Read MoreStockton, CA – As our nation’s blood centers face significant blood donation shortages, growing demand for plasma, and increasing financial strain, Congressman Jerry McNerney (CA-09) co-led a bipartisan letter, along with Representatives Eliot L. Engel (NY-16), Rodney Davis (IL-13), and Brian Fitzpatrick (PA-01), urging House leadership to include assistance for blood centers in the next COVID…
Read MoreWASHINGTON, April 27, 2020 — America’s Blood Centers and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, are announcing a partnership to further promote collections of COVID-19 convalescent plasma (CCP) from individuals who have recovered from…
Read MoreAmerica’s Blood Centers and its members are committed to maintaining a safe and available blood supply and treating all potential donors with fairness, equality, and respect. We commend the U.S. Food and Drug Administration (FDA) for their continued support during this unprecedented situation as our nation coordinates response efforts to COVID-19. In recognizing the need…
Read MoreAABB, America’s Blood Centers (ABC) and the American Red Cross (ARC) are jointly submitting a response to the request for information (RFI) entitled, “Solicitation for Public Comments on Section 209 of the Pandemic and All-Hazards and Advancing Innovation Act”, which was published in the Federal Register on March 23, 2020. Our organizations are pleased that…
Read MoreWashington, D.C. (April 6, 2020) – America’s Blood Centers and its members are working closely with the U.S. Food and Drug Administration (FDA) to collect and distribute convalescent plasma from individuals who have recovered from COVID-19. “Community blood centers are at the forefront of delivering convalescent plasma to patients in critical need. This promising investigational…
Read MoreThe U.S. blood community has joined the U.S. Food and Drug Administration and Biomedical Advanced Research and Development Authority in a national effort to support the collection and distribution of convalescent plasma, a potentially life-saving treatment for critically ill COVID-19 patients. While this coronavirus pandemic is unprecedented, the U.S. blood community has a long history…
Read More